Filing Flows › Iradimed (IRMD) › Net income
Iradimed (IRMD) net income by quarter
Iradimed's net income was $6.5M in Q3 2026 (third quarter 2026), +25% from Q2 2026. Over the last 7 quarters it ranged from $4.7M (Q1 2025) to $6.5M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.5M | +25% | +17% |
| Q2 2026 | $5.2M | -10% | -10% |
| Q1 2026 | $5.8M | -10% | +24% |
| Q4 2025 | $6.4M | +16% | — |
| Q3 2025 | $5.6M | -3% | — |
| Q2 2025 | $5.8M | +23% | — |
| Q1 2025 | $4.7M | — | — |
Q3 2026 at a glance
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Iradimed's net income?
Iradimed's net income was $6.5M in Q3 2026 (third quarter 2026), +25% from Q2 2026.
How has Iradimed's net income changed?
Over the last 7 quarters it ranged from $4.7M (Q1 2025) to $6.5M (Q3 2026).